ARTICLE

FindCenter AddIcon

MDMA’s Journey from Molly to Medicine

By Alfonso Serrano — 2017

MDMA-assisted psychotherapy readies for phase III trials, a last step before possible prescription use in PTSD patients.

Read on www.scientificamerican.com

FindCenter Post-Image

Psychedelics and Race: A Profile of Dr. Monnica T. Williams

The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry

Article
Patricia Kubala
2020
FindCenter AddIcon
FindCenter Post-Image

Can MDMA Be Used to Treat PTSD?

Although ecstasy has been linked to long-term neurological effects and even death—associations that some experts dispute—MDMA has proven safe and non-addictive in some clinical studies. Moreover, MDMA may be effective when combined with psychotherapy to treat PTSD.

Article
Naveed Saleh
2020
FindCenter AddIcon
FindCenter Post-Image

Ecstasy as a Remedy for PTSD? You Probably Have Some Questions.

The drug known by the street names Ecstasy or Molly could be a promising treatment for post-traumatic stress disorder, according to a new study.

Article
Dave Philipps
2018
FindCenter AddIcon
FindCenter Post-Image

MDMA, or Ecstasy, Shows Promise as a PTSD Treatment

Scientists test how pharmaceutical-grade MDMA combines with psychotherapy to help patients with a severe form of PTSD.

Article
Will Stone
2019
FindCenter AddIcon
FindCenter Post-Image

UFC Eyes Psychedelics as Therapy for Fighters’ Brain Injuries

Last month, Ian McCall told HBO’s Real Sports that his 17 years in mixed martial arts led him to a painkiller addiction. “I was medicated and so numbed out from such a young age, I turned into a monster,” he told correspondent David Scott.

Article
Dustin Foote
2021
FindCenter AddIcon
FindCenter Post-Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Article
Maureen Meehan
2017
FindCenter AddIcon

EXPLORE TOPIC

MDMA